These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36977786)

  • 1. Increased renal uptake and urine excretion of oxidized LDL is possibly associated with formation of large calcium oxalate nephrolithiasis: a preliminary study.
    Liu CJ; Ho KT; Tsai YS; Huang HS
    World J Urol; 2023 May; 41(5):1423-1430. PubMed ID: 36977786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is oxidized low-density lipoprotein the connection between atherosclerosis, cardiovascular risk and nephrolithiasis?
    de Freitas ACP; Torres LC; Duarte MDCMB; da Matta MC; Casarini DE; Schor N
    Urolithiasis; 2019 Aug; 47(4):347-356. PubMed ID: 30302491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.
    Crivelli JJ; Mitchell T; Knight J; Wood KD; Assimos DG; Holmes RP; Fargue S
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33379176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
    Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
    FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease.
    Denburg MR; Koepsell K; Lee JJ; Gerber J; Bittinger K; Tasian GE
    J Am Soc Nephrol; 2020 Jun; 31(6):1358-1369. PubMed ID: 32381601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone.
    Zhang X; Liang F; Li T; Jiang Y; Ren F
    Arch Biochem Biophys; 2023 May; 739():109568. PubMed ID: 36914110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of kidney stone formation: an analysis.
    Khan SR
    World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalate transport and calcium oxalate renal stone disease.
    Verkoelen CF; Romijn JC
    Urol Res; 1996; 24(4):183-91. PubMed ID: 8873376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic calcium oxalate nephrolithiasis: a cellular disease.
    Gambaro G; Baggio B
    Scanning Microsc; 1992 Mar; 6(1):247-54. PubMed ID: 1626244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G; Petrarulo M; Nardelotto A; Marangella M; Baggio B
    Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Tamm-Horsfall mucoprotein in calcium oxalate crystallization. N-acetylcysteine--a new therapy for calcium oxalate urolithiasis.
    Fan J; Shen SJ
    Br J Urol; 1994 Sep; 74(3):288-93. PubMed ID: 7953256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney models of calcium oxalate stone formation.
    Robertson WG
    Nephron Physiol; 2004; 98(2):p21-30. PubMed ID: 15499211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine.
    Scholz D; Schwille PO; Ulbrich D; Bausch WM; Sigel A
    Urol Res; 1979 Sep; 7(3):161-70. PubMed ID: 505679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis].
    Gambaro G; Baggio B; Favaro S; Cicerello E; Marchini F; Borsatti A
    Nephrologie; 1984; 5(4):171-2. PubMed ID: 6441892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Differences in Risk Factors for Kidney Stone Formation.
    Zisman AL; Coe FL; Cohen AJ; Riedinger CB; Worcester EM
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1166-1173. PubMed ID: 32561654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyproline stimulates inflammation and reprograms macrophage signaling in a rat kidney stone model.
    Kumar P; Yang Z; Lever JM; Chávez MD; Fatima H; Crossman DK; Maynard CL; George JF; Mitchell T
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166442. PubMed ID: 35562038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
    Gambaro G; Marchini F; Piccoli A; Nassuato MA; Bilora F; Baggio B
    J Am Soc Nephrol; 1996 Apr; 7(4):608-12. PubMed ID: 8724895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.